Insights

Why Australian Pharma Industries, Audinate, NRW, & Vulcan are racing higher

The S&P/ASX 200 Index (ASX: XJO) is back on form on Monday and charging higher. In afternoon trade, the benchmark index…
The post Why Australian Pharma Industries, Audinate, NRW, & Vulcan are racing higher appeared first on The Motley Fool Australia. –

The S&P/ASX 200 Index (ASX: XJO) is back on form on Monday and charging higher. In afternoon trade, the benchmark index is up 0.65% to 7,321 points.

Four ASX shares that are climbing more than most are listed below. Here’s why they are racing higher:

Australian Pharmaceutical Industries Ltd (ASX: API)

The Australian Pharmaceutical Industries share price is rocketing 20% higher to $1.37. This follows news that Wesfarmers Ltd (ASX: WES) has made a takeover offer for the pharmacy chain operator and wholesale distributor. Wesfarmers has offered to acquire the Priceline Pharmacy owner for $1.38 cash per share. This represents a 21% premium to its last close price. Major shareholder Washington H. Soul Pattinson and Co. Ltd (ASX: SOL) has agreed to vote in favour of the proposal.

Audinate Group Ltd (ASX: AD8)

The Audinate share price has jumped 8% to $9.96. Investors have been buying the audio over IP networking solution provider’s shares after brokers responded positively to its recent trading update. One of those brokers is UBS, which has retained its buy rating and lifted its price target to $11.30. UBS was impressed with the update and notes that Audinate’s outlook is strong.

NRW Holdings Limited (ASX: NWH)

The NRW share price is charging 8% higher to $1.67. This morning NRW revealed that Boggabri Coal Operations has exercised an option to acquire the majority of the major mining equipment of Golding Contractors that is engaged under the Maintenance Services and Hire Agreement at the Boggabri Coal Mine. The equipment will be sold for circa $81 million, of which ~$64 million will pay down asset financing debt.

Vulcan Energy Resources Ltd (ASX: VUL)

The Vulcan Energy share price is up over 4% to $8.69. Investors have been buying the lithium explorer’s shares after it was granted a new exploration license. This license is for geothermal energy, geothermal heat, brine, and lithium exploration in the Upper Rhine Valley of Germany for three years. The company notes that the license covers a 108km squared area considered to be prospective for geothermal and lithium brine.

The post Why Australian Pharma Industries, Audinate, NRW, & Vulcan are racing higher appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of May 24th 2021

More reading

ASX 200 midday update: Wesfarmers makes API takeover bid, BHP & Rio Tinto rising

Audinate share price (ASX:AD8) rockets to new all-time high
Australian Pharmaceutical (ASX:API) share price soars 18% on Wesfarmers bid
Wesfarmers (ASX:WES) share price rises on API takeover offer
Why the Vulcan Energy (ASX:VUL) share price is surging higher today

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended AUDINATEGL FPO. The Motley Fool Australia owns shares of and has recommended AUDINATEGL FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!